3-(hydroxymethyl)cyclobutane-1-carbonitrile

Catalog No.: 
ACFTBW183
CAS No.: 
938064-72-3
Molecular Formula: 
C6H9NO
Molecular Weight: 
111.14
3-(hydroxymethyl)cyclobutane-1-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$397.00In stockInquiry
250mg95%$530.00In stockInquiry
1g95%$796.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(hydroxymethyl)cyclobutane-1-carbonitrile
IUPAC Name3-(hydroxymethyl)cyclobutane-1-carbonitrile
MDL No.MFCD13659364
Molecular FormulaC6H9NO
Molecular Weight111.14
SMILESN#CC1CC(CO)C1
InChI KeyGTCQMROOEJOBNO-UHFFFAOYSA-N
Synonym3-(hydroxymethyl)Cyclobutanecarbonitrile;Cyclobutanecarbonitrile, 3-(hydroxymethyl)-;3-(Hydroxymethyl)cyclobutane-1-carbonitrile;1H-Benzimidazole,2-(3-methoxyethyl)-;hydroxymethyl)cyclobutane-1-carbonitrile
CAS No.938064-72-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFTBW183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBSZG645 route compound structure diagram
    ACBSZG6451823933-75-0In Stock
  2. Then
  3. ACFTBW183 route product structure diagram
    ACFTBW183938064-72-3In Stock
Inquiry

2. ACFTBW183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTBW183 route product structure diagram
    ACFTBW183938064-72-3In Stock
Inquiry

3. ACFTBW183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTBW183 route product structure diagram
    ACFTBW183938064-72-3In Stock
Inquiry

Comments (0)